23/05/2026
π GLP-1 Analogues: The New Era in Obesity & Diabetes Management
πΉ Semaglutide: A GLP-1 receptor agonist that increases insulin secretion, reduces glucagon, slows gastric emptying & suppresses appetite.
πΉ Tirzepatide: A dual GIP + GLP-1 receptor agonist offering enhanced glycemic control and greater weight reduction through synergistic metabolic effects.
A major step forward in tackling obesity, diabetes & cardiometabolic disease with science-backed precision therapy.
π¨ββοΈ Dr. Puneet Kumar
Senior Consultant Physician & Diabetes Specialist
π₯ Livasa Hospital
π 75080-38188
π Mon to Sat | 10 AM β 5 PM
π₯ Aggarwal Clinic
#487, Phase 4, Sector 59, Mohali
π 9878228188
π Mon to Sat | 5 PM β 7 PM